Cleantech Transit Inc. (CLNO)
Biomass can be converted to a liquid form for use as a transportation fuel, and research is being conducted on the production of fuels and chemicals from biomass. Biomass materials can also be used directly in the manufacture of a variety of products. Biomass is used for power generation in the electricity sector and for space heating in residential and commercial buildings.
Cleantech Transit Inc is in the business of producing and conserving power. They produce and sell clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind. CLNO was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects.
Cleantech Transit Inc recently announced that funding to be provided to Phoenix Energy for the commercialization of a 500 Kilowatt biomass gasification plant should be eligible to apply for a renewable energy cash back incentive program offered by the U.S. Federal Government. If it concludes its planned investment in Phoenix Energy, under Section 1603 of the American Reinvestment and Recovery Act, Cleantech Transit would be entitled to receive its pro-rata share of 30% cash grant paymentsThe U.S. Treasury’s cash grant program was created to provide funding, in lieu of tax credits, for the development of clean energy projects and clean tech jobs nationwide. The Merced facility has already employed several individuals, both for the construction phase and subsequent plant operations once in service.
For more information, visit www.cleantechtransitinc.com
National Health Partners Inc. (NHPR)
The United States spends twice per capita what other major industrialized countries spend on health care, with $1 of every $5 of national income going toward health care and spending expected to reach $4.2 trillion in 2016, or 20 percent of the GDP. At the same time, the United States was ranked last in preventable mortality among developed nations, just below Ireland and Portugal, with 47 million Americans lacking health insurance, according to the Commonwealth Fund’s analysis of World Health Organization data.
National Health Partners, Inc. is a national healthcare savings organization that provides discount healthcare membership programs to uninsured and underinsured people through a national healthcare savings network called “CARExpress.” CARExpress is one of the largest networks of hospitals, doctors, dentists, pharmacists and other healthcare providers in the country and is comprised of over 1,000,000 medical professionals that belong to such PPOs as CareMark and Aetna. The company’s primary target customer group is the 47 million Americans who have no health insurance of any kind. The company’s secondary target customer group includes the millions of Americans who lack complete health insurance coverage.
Preferred Care / Senior Advantage Program is designed for individuals and families who are underinsured and need to save on the basic health services not covered under a traditional health insurance plan. It offers savings on prescriptions, vision and dental care, and a 24-hour nurseline.
For more information please visit us offical website of NHPR: http://www.nationalhealthpartners.com/index.htm
DexCom, Inc. (Nasdaq:DXCM) announced that Steven Pacelli, Chief Operating Officer, will present an update on DexCom at the ROTH 23rd Annual Growth Stock Conference in Dana Point on Monday, March 14th at 4:00 p.m. (Pacific). The presentation, which will occur live at the Ritz Carlton Laguna Niguel in Dana Point, California, will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at www.dexcom.com under the investor relations, events and webcast section, and will be archived for future reference.
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY) a leading RNAi therapeutics company, announced that management will present a company overview at the Barclays Capital 2011 Global Healthcare Conference on Tuesday, March 15, 2011 at 9:30 a.m. ET at the Loews Miami Hotel in Miami, Florida. In addition, Alnylam management will present a company overview at the Roth 23rd Annual OC Growth Stock Conference on Wednesday, March 16, 2011 at 12:00 p.m. PT at The Ritz Carlton in Laguna Niguel, California. A live audio webcast of the presentations will be available on the “Investors” section of the company’s website, www.alnylam.com. A replay of the presentations will be available on the Alnylam website within 48 hours after the event.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of novel therapeutics based on RNA interference (RNAi).
EnerNOC, Inc. (Nasdaq:ENOC) a leading provider of energy management applications for the smart grid, announced that it has hired Hugh Scandrett as Vice President of Engineering. Mr. Scandrett most recently served as Vice President of Engineering for Kronos Inc., a Massachusetts-based workforce management solutions firm, where he led a global application development team of 425 engineers based in three countries. He previously held leadership positions with Ounce Labs, IBM Rational, DSC Communications, and Nortel, and brings nearly 30 years of experience in the enterprise software and telecommunications industries with him to EnerNOC.
EnerNOC, Inc. engages in the development, implementation, and adoption of demand response and energy management solutions for the electric power grid operators and utilities, as well as commercial, institutional, and industrial end-users of electricity in the United States.
__
No comments:
Post a Comment